Latest Biomarker Stories

TOKYO and GAITHERSBURG, Maryland, Jan. 7, 2013 /PRNewswire/ -- Daiichi Sankyo, Co., Ltd. (hereafter, Daiichi Sankyo) and Amplimmune, Inc. (hereafter, Amplimmune) announced today that they have entered into a broad strategic collaboration to develop a new therapeutic protein, AMP-110 (B7-H4 fusion protein). The collaboration will focus on development of AMP-110, a potential immune modulation therapy for autoimmune diseases. This proprietary, first-in-class biologic works by blocking...

Penn-designed non-invasive MRI screening method is cost-effective, statistically powerful When trying to determine the root cause of a person's dementia, using an MRI can effectively and non-invasively screen patients for Alzheimer's disease or Frontotemporal Lobar Degeneration (FTLD), according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Using an MRI-based algorithm effectively differentiated cases 75 percent of the time, according...

A combination of three blood-borne proteins may bolster efforts to prevent graft loss years after transplant BOSTON, Dec. 26, 2012 /PRNewswire-USNewswire/ -- Researchers at Boston Children's Hospital have found a combination of biomarkers related to blood vessel and tissue injury that, when measured together, could signal when a transplanted heart is becoming damaged to the point of failure, a process that is often undetected. The markers would give doctors an opportunity to...

SUNNYVALE, Calif., Dec. 26, 2012 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced the Company has purchased all of the intellectual property (IP) assets from Power3 Medical Products. Power3 was in bankruptcy, giving Amarantus the ability to acquire all of Power3's the IP for the diagnosis of multiple neurodegenerative diseases and...

MicroRNA molecules potential biomarkers for early cancer detection, reports cancer biomarkers As many as 50 percent of all human protein-coding genes are regulated by microRNA (miRNA) molecules. While some miRNAs impact onset and progression of cancer, others can actually suppress the development of malignant tumors and are useful in cancer therapy. They can also serve as potential biomarkers for early cancer detection. In a new issue of Cancer Biomarkers, investigators report on...

Proteins found in urine may enable diagnosis of Kawasaki disease BOSTON, Dec. 20, 2012 /PRNewswire-USNewswire/ -- A set of proteins detected in urine by researchers at Boston Children's Hospital may prove to be the first biomarkers for Kawasaki disease, an uncommon but increasingly prevalent disease which causes inflammation of blood vessels that can lead to enlarged coronary arteries and even heart attacks in some children. If validated in more patients with Kawasaki disease, the...

Scientists at the Stanford University School of Medicine have identified a set of proteins circulating in blood whose levels accurately flag the presence of lymphedema. The findings, to be reported Dec. 18 in PLoS ONE, spur optimism that this common but relatively neglected condition, which affects an estimated 10 million people in the United States, finally will be amenable to detection (and, eventually, treatment) with 21st-century techniques. Lymphedema is an often-painful inflammatory...

CAMBRIDGE, Mass., Dec. 19, 2012 /PRNewswire/ -- H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of oncology treatments, announced today that it has forged a partnership with Sage Bionetworks to jointly develop software platforms that advance critical components of H3's cancer genomics research. Sage will pair its advanced predictive modeling capabilities and collaboration platform with H3's assimilation of genomic and pharmacology data...

Intellitech's new micro pump promotes the rapid growth for emerging bio tech. The i-FILL® Micro’s disposable fluid path and unmatched dispense accuracy combine to save time and money by eliminating cleaning protocols and reducing product waste. Westminster, MD (PRWEB) December 18, 2012 Intellitech, leading provider of liquid filling equipment for biotech (ELISA kit, reagent, cell therapy, biologics) and pharmaceutical is delivering unmatched performance with the i-FILL®...

Lee Rannals for redOrbit.com – Your Universe Online According to a new study published in the journal Radiology, a combination of a few diagnostic tests could improve prediction of Alzheimer's disease. More than 35 million people around the world are living with Alzheimer's disease, according to the World Health Organization. This disease is incurable and the prevalence is expected to double by 2030. "Although there is no cure for Alzheimer's disease, there are four symptomatic...